May 6 2019
Ekso Bionics Holdings, Inc. a leading manufacturer in exoskeleton technology for industrial and medical applications, recently announced that Kindred Hospital Rehabilitation Services ("Kindred"), a division of Kindred Healthcare, has stretched their pilot of the EksoGT exoskeleton to offer progressive stroke rehabilitation at the majority of their sites — more than 20 freestanding inpatient Kindred rehabilitation hospitals in 13 states.
The pilot started more than a year ago and has since been extended to the majority of their sites, making Kindred Ekso Bionics’ largest partner offering EksoGT at the most locations within one network. Kindred aims to enhance patient results with the EksoGT by mobilizing patients sooner, more frequently, and with a greater number of high-intensity steps during their rehabilitation sessions.
It is our mission to provide greater access to advanced rehabilitation, and we are excited to incorporate the EksoGT into our offering at most of our inpatient rehabilitation hospitals. We believe having access to leading technology can improve patient outcomes, as well as increase their morale during the process. A win-win for our patients.
Russ Bailey, COO/Senior Vice President of Operations, Kindred.
EksoGT is the most extensively used exoskeleton device in rehabilitation, engineered to assist patients get back on their feet by supporting re-learning of accurate step patterns, weight shifting, and potentially alleviating compensatory behaviors, allowing patients to mobilize sooner and reestablish independence. It is the only exoskeleton having SmartAssist software which provides adaptive quantities of power to either side of a patient’s body, particularly advantageous for stroke patients.
Innovative customers like Kindred are in a position to advance stroke rehabilitation by equipping their clinicians with EksoGT. With locations throughout the country, Kindred is able to improve more patients’ lives and is leading the way in changing the standard of care.
Jack Peurach, CEO and President, Ekso Bionics.